• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镓(III)纳米颗粒抑制结核分枝杆菌和HIV的生长以及共感染巨噬细胞中白细胞介素-6(IL-6)和IL-8的释放。

Ga(III) Nanoparticles Inhibit Growth of both Mycobacterium tuberculosis and HIV and Release of Interleukin-6 (IL-6) and IL-8 in Coinfected Macrophages.

作者信息

Choi Seoung-Ryoung, Britigan Bradley E, Narayanasamy Prabagaran

机构信息

Department of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.

出版信息

Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02505-16. Print 2017 Apr.

DOI:10.1128/AAC.02505-16
PMID:28167548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5365726/
Abstract

Treatment of individuals coinfected with human immunodeficiency virus (HIV) type 1 and is challenging due to the prolonged treatment requirements, drug toxicity, and emergence of drug resistance. Mononuclear phagocytes (MP; macrophages) are one of the natural reservoirs for both HIV and Here, the treatment of HIV and coinfection was studied by preloading human macrophages with MP-targeted gallium (Ga) nanoparticles to limit subsequent simultaneous infection with both HIV and Ga nanoparticles provided sustained drug release for 15 days and significantly inhibited the replication of both HIV and Addition of Ga nanoparticles to MP already infected with or HIV resulted in a significant decrease in the magnitude of these infections, but the magnitude was less than that achieved with nanoparticle preloading of the MP. In addition, macrophages that were coinfected with HIV and and that were loaded with Ga nanoparticles reduced the levels of interleukin-6 (IL-6) and IL-8 secretion for up to 15 days after drug loading. Ga nanoparticles also reduced the levels of IL-6 and IL-8 secretion by ionomycin- and lipopolysaccharide-induced macrophages, likely by modulating the IκB kinase-β/NF-κB pathway. Delivery of Ga nanoparticles to macrophages is a potent long-acting approach for suppressing HIV and coinfection of macrophages and sets the stage for the development of new approaches to the treatment of these important infections.

摘要

由于治疗时间长、药物毒性以及耐药性的出现,同时感染1型人类免疫缺陷病毒(HIV)和[此处原文缺失病原体名称]的个体的治疗具有挑战性。单核吞噬细胞(MP;巨噬细胞)是HIV和[此处原文缺失病原体名称]的天然储存库之一。在此,通过用靶向MP的镓(Ga)纳米颗粒预加载人类巨噬细胞来研究HIV和[此处原文缺失病原体名称]合并感染的治疗,以限制随后同时感染HIV和[此处原文缺失病原体名称]。Ga纳米颗粒提供了15天的持续药物释放,并显著抑制了HIV和[此处原文缺失病原体名称]的复制。向已感染[此处原文缺失病原体名称]或HIV的MP中添加Ga纳米颗粒导致这些感染的程度显著降低,但降低程度小于对MP进行纳米颗粒预加载所达到的程度。此外,同时感染HIV和[此处原文缺失病原体名称]并加载了Ga纳米颗粒的巨噬细胞在药物加载后长达15天内降低了白细胞介素-6(IL-6)和IL-8的分泌水平。Ga纳米颗粒还可能通过调节IκB激酶-β/核因子κB(NF-κB)途径降低了离子霉素和脂多糖诱导的巨噬细胞中IL-6和IL-8的分泌水平。将Ga纳米颗粒递送至巨噬细胞是一种抑制巨噬细胞HIV和[此处原文缺失病原体名称]合并感染的有效长效方法,并为开发治疗这些重要感染的新方法奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e0/5365726/3c5ebdd918af/zac0041760690007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e0/5365726/5f9b90a244de/zac0041760690001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e0/5365726/745ef7176ce1/zac0041760690002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e0/5365726/5d9e48e28a85/zac0041760690003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e0/5365726/8a75a6ac0abf/zac0041760690004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e0/5365726/17b4511042c0/zac0041760690005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e0/5365726/e08aba3fb5c3/zac0041760690006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e0/5365726/3c5ebdd918af/zac0041760690007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e0/5365726/5f9b90a244de/zac0041760690001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e0/5365726/745ef7176ce1/zac0041760690002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e0/5365726/5d9e48e28a85/zac0041760690003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e0/5365726/8a75a6ac0abf/zac0041760690004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e0/5365726/17b4511042c0/zac0041760690005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e0/5365726/e08aba3fb5c3/zac0041760690006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e0/5365726/3c5ebdd918af/zac0041760690007.jpg

相似文献

1
Ga(III) Nanoparticles Inhibit Growth of both Mycobacterium tuberculosis and HIV and Release of Interleukin-6 (IL-6) and IL-8 in Coinfected Macrophages.镓(III)纳米颗粒抑制结核分枝杆菌和HIV的生长以及共感染巨噬细胞中白细胞介素-6(IL-6)和IL-8的释放。
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02505-16. Print 2017 Apr.
2
Treatment of Virulent Mycobacterium tuberculosis and HIV Coinfected Macrophages with Gallium Nanoparticles Inhibits Pathogen Growth and Modulates Macrophage Cytokine Production.用镓纳米粒子治疗毒力结核分枝杆菌和 HIV 共感染的巨噬细胞可抑制病原体生长并调节巨噬细胞细胞因子的产生。
mSphere. 2019 Jul 24;4(4):e00443-19. doi: 10.1128/mSphere.00443-19.
3
Prolonged-acting, multi-targeting gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected human macrophages.长效多靶点镓纳米颗粒可有效抑制合并感染的人类巨噬细胞中HIV和分枝杆菌的生长。
Sci Rep. 2015 Mar 6;5:8824. doi: 10.1038/srep08824.
4
Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages.镓纳米颗粒促进吞噬体成熟并抑制巨噬细胞中有毒力结核分枝杆菌的生长。
PLoS One. 2017 May 18;12(5):e0177987. doi: 10.1371/journal.pone.0177987. eCollection 2017.
5
Infection of human monocytes with Mycobacterium tuberculosis enhances human immunodeficiency virus type 1 replication and transmission to T cells.结核分枝杆菌感染人类单核细胞会增强1型人类免疫缺陷病毒的复制并促进其向T细胞的传播。
J Infect Dis. 1997 Jun;175(6):1531-5. doi: 10.1086/516494.
6
Phosphatidylserine Liposomes Reduce Inflammatory Response, Mycobacterial Viability, and HIV Replication in Coinfected Human Macrophages.磷脂酰丝氨酸脂质体可减少感染人类巨噬细胞中的炎症反应、分枝杆菌活力和 HIV 复制。
J Infect Dis. 2022 May 4;225(9):1675-1679. doi: 10.1093/infdis/jiab602.
7
PknE, a serine/threonine protein kinase of Mycobacterium tuberculosis initiates survival crosstalk that also impacts HIV coinfection.PknE是结核分枝杆菌的一种丝氨酸/苏氨酸蛋白激酶,它启动了生存串扰,这也会影响HIV合并感染。
PLoS One. 2014 Jan 8;9(1):e83541. doi: 10.1371/journal.pone.0083541. eCollection 2014.
8
Effects of in vitro HIV-1 infection on mycobacterial growth in peripheral blood monocyte-derived macrophages.体外 HIV-1 感染对人外周血单核细胞衍生巨噬细胞中分枝杆菌生长的影响。
Infect Immun. 2010 Sep;78(9):4022-32. doi: 10.1128/IAI.00106-10. Epub 2010 Jul 12.
9
Efferocytosis of Apoptotic Neutrophils Enhances Control of Mycobacterium tuberculosis in HIV-Coinfected Macrophages in a Myeloperoxidase-Dependent Manner.凋亡中性粒细胞的胞葬作用以髓过氧化物酶依赖的方式增强了对HIV合并感染巨噬细胞中结核分枝杆菌的控制。
J Innate Immun. 2020;12(3):235-247. doi: 10.1159/000500861. Epub 2019 Jun 27.
10
HIV-1 infection of macrophages dysregulates innate immune responses to Mycobacterium tuberculosis by inhibition of interleukin-10.HIV-1 感染巨噬细胞通过抑制白细胞介素-10 来扰乱对结核分枝杆菌的固有免疫反应。
J Infect Dis. 2014 Apr 1;209(7):1055-65. doi: 10.1093/infdis/jit621. Epub 2013 Nov 21.

引用本文的文献

1
Efficacy and Possible Mechanism(s) of Action of Gallium Tetraphenylporphyrin Nanoparticles against HIV-TB Coinfection in an Granuloma Structure Model.四苯基卟啉镓纳米颗粒在肉芽肿结构模型中抗HIV-TB合并感染的疗效及可能的作用机制
ACS Infect Dis. 2024 Dec 13;10(12):4279-4290. doi: 10.1021/acsinfecdis.4c00639. Epub 2024 Nov 5.
2
Leading Paediatric Infectious Diseases-Current Trends, Gaps, and Future Prospects in Oral Pharmacotherapeutic Interventions.前沿儿科传染病——口服药物治疗干预的当前趋势、差距及未来前景
Pharmaceutics. 2024 May 26;16(6):712. doi: 10.3390/pharmaceutics16060712.
3
A Novel Vision of Reinforcing Nanofibrous Masks with Metal Nanoparticles: Antiviral Mechanisms Investigation.

本文引用的文献

1
Novel long-chain compounds with both immunomodulatory and MenA inhibitory activities against Staphylococcus aureus and its biofilm.具有免疫调节和 MenA 抑制活性的新型长链化合物,可抑制金黄色葡萄球菌及其生物膜。
Sci Rep. 2017 Jan 10;7:40077. doi: 10.1038/srep40077.
2
Targeted Delivery of Glucan Particle Encapsulated Gallium Nanoparticles Inhibits HIV Growth in Human Macrophages.靶向递送葡聚糖颗粒包裹的镓纳米颗粒可抑制HIV在人巨噬细胞中的生长。
J Drug Deliv. 2016;2016:8520629. doi: 10.1155/2016/8520629. Epub 2016 Nov 14.
3
Discovery of bicyclic inhibitors against menaquinone biosynthesis.
用金属纳米颗粒增强纳米纤维口罩的新视角:抗病毒机制研究
Adv Fiber Mater. 2023 Apr 11:1-45. doi: 10.1007/s42765-023-00275-7.
4
A Current Perspective on the Potential of Nanomedicine for Anti-Tuberculosis Therapy.纳米医学在抗结核治疗中的潜力现状展望
Trop Med Infect Dis. 2023 Feb 3;8(2):100. doi: 10.3390/tropicalmed8020100.
5
Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages.靶向巨噬细胞治疗结核病的药物递送最新进展
Adv Ther (Weinh). 2022 Jun;5(6). doi: 10.1002/adtp.202100193. Epub 2022 Mar 9.
6
Monocytes as a convergent nanoparticle therapeutic target for cardiovascular diseases.单核细胞作为心血管疾病治疗的一种趋同纳米颗粒治疗靶点。
Adv Drug Deliv Rev. 2022 Mar;182:114116. doi: 10.1016/j.addr.2022.114116. Epub 2022 Jan 24.
7
Immunologic biomarkers, morbidity and mortality among HIV patients hospitalised in a Tertiary Care Hospital in the Brazilian Amazon.巴西亚马逊地区一家三级护理医院收治的 HIV 患者的免疫生物标志物、发病率和死亡率。
BMC Infect Dis. 2021 Aug 26;21(1):876. doi: 10.1186/s12879-021-06566-x.
8
Metal-Based Nanomaterials: Work as Drugs and Carriers against Viral Infections.金属基纳米材料:作为抗病毒感染的药物和载体发挥作用。
Nanomaterials (Basel). 2021 Aug 20;11(8):2129. doi: 10.3390/nano11082129.
9
Nanotechnology for virus treatment.用于病毒治疗的纳米技术。
Nano Today. 2021 Feb;36:101031. doi: 10.1016/j.nantod.2020.101031. Epub 2020 Dec 1.
10
Approaches to treating tuberculosis by encapsulating metal ions and anti-mycobacterial drugs utilizing nano- and microparticle technologies.利用纳米和微粒子技术将金属离子和抗分枝杆菌药物包封来治疗结核病的方法。
Emerg Top Life Sci. 2020 Dec 17;4(6):581-600. doi: 10.1042/ETLS20190154.
针对甲萘醌生物合成的双环抑制剂的发现。
Future Med Chem. 2016 Jan;8(1):11-6. doi: 10.4155/fmc.15.168.
4
Binding of CXCL8/IL-8 to Mycobacterium tuberculosis Modulates the Innate Immune Response.CXCL8/白细胞介素-8与结核分枝杆菌的结合调节先天性免疫反应。
Mediators Inflamm. 2015;2015:124762. doi: 10.1155/2015/124762. Epub 2015 Aug 2.
5
Herpes simplex virus type 2-infected dendritic cells produce TNF-α, which enhances CCR5 expression and stimulates HIV production from adjacent infected cells.2型单纯疱疹病毒感染的树突状细胞产生肿瘤坏死因子-α,其可增强趋化因子受体5(CCR5)的表达,并刺激相邻受感染细胞产生HIV。
J Immunol. 2015 May 1;194(9):4438-45. doi: 10.4049/jimmunol.1401706. Epub 2015 Apr 3.
6
Prolonged-acting, multi-targeting gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected human macrophages.长效多靶点镓纳米颗粒可有效抑制合并感染的人类巨噬细胞中HIV和分枝杆菌的生长。
Sci Rep. 2015 Mar 6;5:8824. doi: 10.1038/srep08824.
7
Patterns of HIV, TB, and non-communicable disease multi-morbidity in peri-urban South Africa- a cross sectional study.南非城郊地区艾滋病毒、结核病和非传染性疾病多重共病模式——一项横断面研究
BMC Infect Dis. 2015 Jan 17;15:20. doi: 10.1186/s12879-015-0750-1.
8
Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study.在中等结核病负担地区,对感染艾滋病毒患者采用异烟肼预防性治疗预防结核病的长期效果:里约热内卢结核病/艾滋病毒(THRio)研究
Clin Infect Dis. 2015 Feb 15;60(4):639-45. doi: 10.1093/cid/ciu849. Epub 2014 Nov 2.
9
Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.长效抗结核治疗纳米颗粒靶向巨噬细胞内体。
FASEB J. 2014 Dec;28(12):5071-82. doi: 10.1096/fj.14-255786. Epub 2014 Aug 13.
10
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.全球、区域和国家在 1990-2013 年间艾滋病毒、结核病和疟疾的发病率和死亡率:2013 年全球疾病负担研究的系统分析。
Lancet. 2014 Sep 13;384(9947):1005-70. doi: 10.1016/S0140-6736(14)60844-8. Epub 2014 Jul 22.